The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 09, 2020
Filed:
Oct. 12, 2016
Applicant:
Aprogen Kic Inc., Seongnam-si, KR;
Inventors:
Kwon Pyo Hong, Cheongju-si, KR;
Sangsoon Yoon, Seoul, KR;
Irene Koukoulas, Watsonia North, AU;
Vincent Batori, Munich, DE;
Briony Cristiano, Gaithersburg, MA (US);
David S Wilson, Jr., Redwood City, CA (US);
George Kopsidas, Preston, AU;
Assignee:
APROGEN KIC INC., Seongnam-si, KR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/395 (2006.01); A61P 35/00 (2006.01); A61K 45/06 (2006.01); G01N 33/50 (2006.01); G01N 33/574 (2006.01); A61K 39/00 (2006.01); A61K 47/68 (2017.01); A61K 38/16 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2896 (2013.01); A61K 39/00 (2013.01); A61K 39/395 (2013.01); A61K 45/06 (2013.01); A61K 47/6803 (2017.08); A61P 35/00 (2018.01); G01N 33/50 (2013.01); G01N 33/574 (2013.01); A61K 38/16 (2013.01); A61K 2039/505 (2013.01); A61K 2300/00 (2013.01); C07K 2317/24 (2013.01); C07K 2317/34 (2013.01); C07K 2317/41 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/72 (2013.01); C07K 2317/732 (2013.01); C07K 2317/734 (2013.01); C07K 2317/77 (2013.01); C07K 2319/55 (2013.01);
Abstract
Provided is an antibody for treating a cancer, more specifically, an anti-CD43 antibody binding to an extracellular domain of CD43, compositions for treating a cancer or inhibiting a cancer stem cell comprising the antibody as an active ingredient, and methods for screening an agent of inhibiting a cancer stem cell.